Focusing entirely about the GMP could lead to overvaluation in an IPO, resulting in lousy investment possibilities if the hoopla would not translate into reality. Zero legal protection The IPO comprises a refreshing concern of approximately sixty five lakh equity shares and a suggestion available (OFS) of 35 lakh fairness shares because of the p